APA

Bilen M. A., Patel A., Hess K. R., Munoz J., Busaidy N. L., Wheler J. J., Janku F., Falchook G. S., Hong D. S., Meric-Bernstam F., Habra M. A. & Naing A. (20170606). Association between new-onset hypothyroidism and clinical response in patients treated with tyrosine kinase inhibitor therapy in phase I clinical trials. : Cancer chemotherapy and pharmacology.

Chicago

Bilen Mehmet Asim, Patel Amy, Hess Kenneth R, Munoz Javier, Busaidy Naifa L, Wheler Jennifer J, Janku Filip, Falchook Gerald S, Hong David S, Meric-Bernstam Funda, Habra Mouhammed Amir and Naing Aung. 20170606. Association between new-onset hypothyroidism and clinical response in patients treated with tyrosine kinase inhibitor therapy in phase I clinical trials. : Cancer chemotherapy and pharmacology.

Harvard

Bilen M. A., Patel A., Hess K. R., Munoz J., Busaidy N. L., Wheler J. J., Janku F., Falchook G. S., Hong D. S., Meric-Bernstam F., Habra M. A. and Naing A. (20170606). Association between new-onset hypothyroidism and clinical response in patients treated with tyrosine kinase inhibitor therapy in phase I clinical trials. : Cancer chemotherapy and pharmacology.

MLA

Bilen Mehmet Asim, Patel Amy, Hess Kenneth R, Munoz Javier, Busaidy Naifa L, Wheler Jennifer J, Janku Filip, Falchook Gerald S, Hong David S, Meric-Bernstam Funda, Habra Mouhammed Amir and Naing Aung. Association between new-onset hypothyroidism and clinical response in patients treated with tyrosine kinase inhibitor therapy in phase I clinical trials. : Cancer chemotherapy and pharmacology. 20170606.